Yuqin Song

Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase

Yuqin Song, Keshu Zhou, Dehui Zou et al. · Clinical Cancer Research · 2020 · 183 citations

Medicine, Oncology, Pharmacology +17

The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages

Lingyan Ping, Ning Ding, Yunfei Shi et al. · Oncotarget · 2017 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies

Constantine S. Tam, Meletios Α. Dimopoulos, Ramón García‐Sánz et al. · Blood Advances · 2021 · 85 citations · Full text

Medicine, Oncology, Pharmacology +17

Peroxisome proliferator activated receptor-γ ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells

Jiajun Liu, Huiling Lü, Renwei Huang et al. · Cancer Chemotherapy and Pharmacology · 2005 · 48 citations

Medicine, Cell Biology, Oncology +14

The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial

Tingyu Wang, Xiuhua Sun, Lihua Qiu et al. · Clinical Cancer Research · 2023 · 38 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13